Patrick P. Grace Sells 400 Shares of Chemed Corp. (CHE) Stock
Chemed Corp. (NYSE:CHE) Director Patrick P. Grace sold 400 shares of the business’s stock in a transaction dated Monday, November 28th. The stock was sold at an average price of $148.53, for a total transaction of $59,412.00. Following the sale, the director now owns 4,597 shares in the company, valued at $682,792.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Chemed Corp. (NYSE:CHE) opened at 150.03 on Wednesday. The stock’s 50 day moving average price is $141.89 and its 200-day moving average price is $138.01. Chemed Corp. has a 12 month low of $124.77 and a 12 month high of $159.76. The firm has a market capitalization of $2.43 billion, a P/E ratio of 23.95 and a beta of 1.25.
Chemed Corp. (NYSE:CHE) last issued its quarterly earnings results on Wednesday, October 26th. The company reported $1.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.82 by $0.09. Chemed Corp. had a return on equity of 23.95% and a net margin of 6.77%. The business earned $392.61 million during the quarter, compared to analyst estimates of $270.44 million. During the same period in the previous year, the business posted $1.78 earnings per share. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. On average, analysts forecast that Chemed Corp. will post $7.24 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 5th. Shareholders of record on Monday, November 14th will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Wednesday, November 9th. Chemed Corp.’s payout ratio is 16.59%.
A number of hedge funds have recently modified their holdings of the company. Emerald Acquisition Ltd. acquired a new stake in shares of Chemed Corp. during the second quarter worth about $26,177,000. Fiera Capital Corp acquired a new stake in shares of Chemed Corp. during the second quarter worth about $17,291,000. BlackRock Fund Advisors raised its stake in shares of Chemed Corp. by 6.2% in the third quarter. BlackRock Fund Advisors now owns 1,109,056 shares of the company’s stock worth $156,455,000 after buying an additional 64,981 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Chemed Corp. by 3.1% in the second quarter. Vanguard Group Inc. now owns 1,576,155 shares of the company’s stock worth $214,846,000 after buying an additional 46,726 shares during the last quarter. Finally, Marshall Wace LLP acquired a new stake in shares of Chemed Corp. during the second quarter worth about $5,483,000. 97.40% of the stock is currently owned by hedge funds and other institutional investors.
A number of analysts have issued reports on the stock. Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $155.00 price target on shares of Chemed Corp. in a research note on Tuesday, September 27th. Zacks Investment Research lowered shares of Chemed Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, November 1st. JMP Securities reiterated a “hold” rating on shares of Chemed Corp. in a research note on Sunday, September 4th. Royal Bank Of Canada cut their price target on shares of Chemed Corp. from $162.00 to $148.00 and set a “sector perform” rating on the stock in a research note on Tuesday, November 1st. Finally, RBC Capital Markets reiterated a “sector perform” rating and set a $148.00 price target (down from $162.00) on shares of Chemed Corp. in a research note on Tuesday, November 1st. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $154.50.
About Chemed Corp.
Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.